The Burden of Obstructive Lung Disease (BOLD) study in Australia

Christine F McDonald and Nicholas Glasgow
Med J Aust 2013; 198 (3): . || doi: 10.5694/mja13.10031
Published online: 18 February 2013

The implications for practice and policy of new national prevalence data

In this issue of the Journal, Toelle and colleagues provide up-to-date information about obstructive lung diseases in Australia in their report on the Australian arm of the Burden of Obstructive Lung Disease (BOLD) study.1 The BOLD study is an international collaboration comparing rates of obstructive lung disease in people aged 40 years or older in 12 countries. Sydney’s place in this international league table was reported previously,2 but now we have access to Australia-wide data, with six sites chosen specifically to ensure adequate representation of the states and territories and, importantly, to include Indigenous groups. Given that the overall participation rate in this study was only 27%, it is possible that the disease burden may be greater or less than estimated, but these data nevertheless allow more robust international comparisons than have previously been possible.

  • Christine F McDonald1
  • Nicholas Glasgow2

  • 1 Department of Respiratory and Sleep Medicine, Austin Hospital, Melbourne, VIC.
  • 2 College of Medicine, Biology and Environment, Australian National University, Canberra, ACT.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.